Aethlon Medical, Inc. Share Price
NASDAQ: AEMD | Micro Cap$5.43
+$5.43 (--%) Last updated on 31 Oct, 2026 | 00:42 ISTAethlon Medical, Inc. Stock Performance
Aethlon Medical, Inc. Share Price Chart
$5.43$5.43
L
H
Aethlon Medical, Inc. Quarterly Profit & Loss
All figures in USD
Aethlon Medical, Inc. Annual Profit & Loss
All figures in USD
About Aethlon Medical, Inc.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
Aethlon Medical, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $6.64 | $5.43 | -15.81% |
Sep 2026 | $1.88 | $6.45 | +108.06% |
Aug 2026 | $0.64 | $3.10 | +371.12% |
Jul 2026 | $0.71 | $0.66 | -20.72% |
Jun 2026 | $2.20 | $0.83 | -62.44% |
May 2026 | $2.30 | $2.21 | -1.34% |
Apr 2026 | $2.20 | $2.24 | +2.75% |
Mar 2026 | $1.80 | $2.18 | +6.86% |
Feb 2026 | $2.42 | $2.04 | -18.56% |
Jan 2026 | $2.70 | $2.50 | -1.96% |
Dec 2025 | $4.32 | $2.56 | -35.96% |
Nov 2025 | $4.60 | $3.99 | -27.59% |